Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery
暂无分享,去创建一个
[1] J F Glenn,et al. Prospects and challenges. , 1967, The Journal of urology.
[2] Andrew Murray,et al. All's well that ends well , 1990, Nature.
[3] P Green,et al. Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.
[4] angesichts der Corona-Pandemie,et al. UPDATE , 1973, The Lancet.
[5] P. Green,et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.
[6] Luigi Naldini,et al. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.
[7] R. Kanaar,et al. DNA double-strand break repair: all's well that ends well. , 2006, Annual review of genetics.
[8] N. Trede,et al. Method for isolation of PCR-ready genomic DNA from zebrafish tissues. , 2007, BioTechniques.
[9] Shohei Koyama,et al. Innate immune response to viral infection. , 2008, Cytokine.
[10] D. Schatz,et al. Balancing AID and DNA repair during somatic hypermutation. , 2009, Trends in immunology.
[11] Chantal Pichon,et al. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers , 2009, British journal of pharmacology.
[12] Richard Heller,et al. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] Anton Nekrutenko,et al. Manipulation of FASTQ data with Galaxy , 2010, Bioinform..
[14] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[15] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[16] David R. Liu,et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity , 2013, Nature Biotechnology.
[17] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[18] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[19] J. Keith Joung,et al. Broad Specificity Profiling of TALENs Results in Engineered Nucleases With Improved DNA Cleavage Specificity , 2014, Nature Methods.
[20] Yao-Cheng Lin,et al. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations , 2014, Nature Communications.
[21] J. Doudna,et al. The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.
[22] Hao Yin,et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.
[23] Steven Lin,et al. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery , 2014, eLife.
[24] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[25] Mazhar Adli,et al. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction , 2015, Nucleic acids research.
[26] Randall J. Platt,et al. Therapeutic genome editing: prospects and challenges , 2015, Nature Medicine.
[27] Charles A Gersbach,et al. Enabling functional genomics with genome engineering , 2015, Genome research.
[28] David R. Liu,et al. Small Molecule-Triggered Cas9 Protein with Improved Genome-Editing Specificity , 2015, Nature chemical biology.
[29] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[30] Martin J. Aryee,et al. GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases , 2014, Nature Biotechnology.
[31] J. Keith Joung,et al. Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo , 2014, Nature Biotechnology.
[32] Namritha Ravinder,et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. , 2015, Journal of biotechnology.
[33] A. Kondo,et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems , 2016, Science.
[34] David R. Liu,et al. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases. , 2016, Cell chemical biology.
[35] Dana Carroll,et al. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells , 2016, Science Translational Medicine.
[36] Irene Georgakoudi,et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles , 2016, Proceedings of the National Academy of Sciences.
[37] A. Edge,et al. Diphtheria Toxin-Induced Cell Death Triggers Wnt-Dependent Hair Cell Regeneration in Neonatal Mice , 2016, The Journal of Neuroscience.
[38] David R. Liu,et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.
[39] Jacob E Corn,et al. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA , 2016, Nature Biotechnology.
[40] Gaelen T. Hess,et al. Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells , 2016, Nature Methods.
[41] J. Keith Joung,et al. 731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects , 2016 .
[42] Meagan E. Sullender,et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.
[43] Yan Song,et al. Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells , 2016, Nature Methods.
[44] John Chilton,et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update , 2016, Nucleic Acids Res..
[45] Yunde Zhao,et al. Generation of Targeted Point Mutations in Rice by a Modified CRISPR/Cas9 System. , 2017, Molecular plant.
[46] Daesik Kim,et al. Highly efficient RNA-guided base editing in mouse embryos , 2017, Nature Biotechnology.
[47] David R. Liu,et al. CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes , 2017, Cell.
[48] Marius van den Beek,et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update , 2018, Nucleic Acids Res..